Catalyst Wire Dossier Catalyst Wire Dossier

tiotropium inhalation powder

tiotropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tiotropium inhalation powder, covering 2023-12-01 to 2023-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing